Assignee
NANTONG YICHEN BIOPHARMA CO LTD
CN·0 granted patents·9 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
9 records- 0163US2024417433A1Bispecific Binding MoleculeNANTONG YICHEN BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0254US2023095979A1Epitope-directed antibody selection by photocrosslinkingNANTONG YICHEN BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0352US2024425546A1Epitope ModificationNANTONG YICHEN BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0447US2023287081A1PD-1 mutant polypeptide and preparation and application thereofNANTONG YICHEN BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0547US2022411530A1PSMA Antibody and Use ThereofNANTONG YICHEN BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0646US2022289838A1Immunocytokine, Preparation for the Same, and Uses ThereofNANTONG YICHEN BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0745US2022233710A1Bispecific molecule and preparation and use thereofNANTONG YICHEN BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0844US2022185903A1Novel bispecific binding molecule and drug conjugate thereofNANTONG YICHEN BIOPHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0944US2022089722A1Heterodimeric fusion proteinNANTONG YICHEN BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANTONG YICHEN BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →